Simulation Safety References

Risks and Incidents Involving Simulated Medications 

Schroeder, J., O’Neal, C., & Jagneaux, T. (2015). Practically Saline. Journal of investigative medicine high impact case reports, 3(4), 2324709615618980. doi:10.1177/2324709615618980

Torrie J, Cumin D, Sheridan J, Merry AF. Fake and expired medications in simulation-based education: An underappreciated risk to patient safety. BMJ Quality and Safety 2016;25(12):917-20. doi: 10.1136/bmjqs-2015-004793

Strategies and Policy Development

Bajaj K, Minors A, Walker K, Meguerdichian M, Patterson M. No-Go Considerations” for In Situ Simulation Safety.  Simul Healthc. 2018 Apr 4.

Brazil, V., Scott, C., Matulich, J. et al. Developing a simulation safety policy for translational simulation programs in healthcare. Adv Simul 7, 4 (2022).

Brazil V, Purdy E. Simulation Safety Spotlight – a call for Safety briefings in sim. International Clinical Educators Network Royal College of Physicians and Surgeons of Canada. 2019. Accessed February 27, 2022.

Simulation Safety Editorial 

Simulation Safety First: An Imperative

Raemer, D, Hannenberg, A, Mullen, A. Simulation Safety First; An Imperative.  Simul  Healthc. 2018  Dec.

Raemer DB. Ignaz Semmelweis Redux? Simul Healthc. 2014 Jun;9(3):153-5. PMID 24401925

Simulation Safety Editorial : Portuguese Translation


Simulation Safety First Editorial;  Translated by Henrique Pierotti Arantes, MD and Carolina Alexio.

Simulation Safety Editorial : Spanish Translation

Primero la Seguridad en la Simulación* Un imperativ

Simulation Safety First Editorial;  Translated by Priscilla Carmiol-Rodríguez, Revisions by Demian Szyld and Jose M. Maestre